| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.005 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.005 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.005 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.16 | 0.006 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.093 | 0.008 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.009 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.13 | 0.01 |